Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibitionTamara Isermann, Ramona Schulz‐Heddergott|Cell Death and Differentiation|2025Cited by 9
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibitionTamara Isermann, Ramona Schulz‐Heddergott|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 1